![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Article |
|---|---|
| Title: | The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): its goals, rationale, data infrastructure, and current developments |
| Creators Name: | Kwong, R.Y., Petersen, S.E., Schulz-Menger, J., Arai, A.E., Bingham, S.E., Chen, Y., Choi, Y.L., Cury, R.C., Ferreira, V.M., Flamm, S.D., Steel, K., Bandettini, W.P., Martin, E.T., Nallamshetty, L., Neubauer, S., Raman, S.V., Schelbert, E.B., Valeti, U.S., Cao, J.J., Reichek, N., Young, A.A., Fexon, L., Pivovarov, M., Ferrari, V.A. and Simonetti, O.P. |
| Abstract: | BACKGROUND: With multifaceted imaging capabilities, cardiovascular magnetic resonance (CMR) is playing a progressively increasing role in the management of various cardiac conditions. A global registry that harmonizes data from international centers, with participation policies that aim to be open and inclusive of all CMR programs, can support future evidence-based growth in CMR. METHODS: The Global CMR Registry (GCMR) was established in 2013 under the auspices of the Society for Cardiovascular Magnetic Resonance (SCMR). The GCMR team has developed a web-based data infrastructure, data use policy and participation agreement, data-harmonizing methods, and site-training tools based on results from an international survey of CMR programs. RESULTS: At present, 17 CMR programs have established a legal agreement to participate in GCMR, amongst them 10 have contributed CMR data, totaling 62,456 studies. There is currently a predominance of CMR centers with more than 10 years of experience (65%), and the majority are located in the United States (63%). The most common clinical indications for CMR have included assessment of cardiomyopathy (21%), myocardial viability (16%), stress CMR perfusion for chest pain syndromes (16%), and evaluation of etiology of arrhythmias or planning of electrophysiological studies (15%) with assessment of cardiomyopathy representing the most rapidly growing indication in the past decade. Most CMR studies involved the use of gadolinium-based contrast media (95%). CONCLUSION: We present the goals, mission and vision, infrastructure, preliminary results, and challenges of the GCMR. TRIAL REGISTRATION: Identification number on ClinicalTrials.gov: NCT02806193. Registered 17 June 2016. |
| Keywords: | Registry, Cardiovascular Magnetic Resonance, Imaging, Patient Management, Therapeutic Implications |
| Source: | Journal of Cardiovascular Magnetic Resonance |
| ISSN: | 1097-6647 |
| Publisher: | BioMed Central |
| Volume: | 19 |
| Number: | 1 |
| Page Range: | 23 |
| Date: | 20 January 2017 |
| Official Publication: | https://doi.org/10.1186/s12968-016-0321-7 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
